Cargando…
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems
Background. Innovative drugs targeting the PD1/PD-L1 axis have opened promising scenarios in modern cancer therapy. Plenty of assays and scoring systems have been developed for the evaluation of PD-L1 immunohistochemical expression, so far considered the most reliable therapeutic predictive marker....
Autores principales: | Marletta, Stefano, Fusco, Nicola, Munari, Enrico, Luchini, Claudio, Cimadamore, Alessia, Brunelli, Matteo, Querzoli, Giulia, Martini, Maurizio, Vigliar, Elena, Colombari, Romano, Girolami, Ilaria, Pagni, Fabio, Eccher, Albino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321150/ https://www.ncbi.nlm.nih.gov/pubmed/35887569 http://dx.doi.org/10.3390/jpm12071073 |
Ejemplares similares
-
Relevance of the College of American Pathologists guideline for validating whole slide imaging for diagnostic purposes to cytopathology
por: Antonini, Pietro, et al.
Publicado: (2022) -
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma
por: Girolami, Ilaria, et al.
Publicado: (2023) -
Validation of portable tablets for transplant pathology diagnosis according to the College of American Pathologists Guidelines
por: Marletta, Stefano, et al.
Publicado: (2022) -
Commentary: The Digital Fate of Glomeruli in Renal Biopsy
por: Girolami, Ilaria, et al.
Publicado: (2021) -
PD‐L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside
por: Nocini, Riccardo, et al.
Publicado: (2022)